Dr. Eric A. Ortlund's lab focuses on understanding and targeting a specific protein, LRH-1, which plays a key role in managing how our bodies process fats and sugars. By developing new small molecules that can activate LRH-1, the lab aims to find therapeutic solutions for diseases linked to obesity, like diabetes and fatty liver disease. They also create innovative mouse models to test these new treatments more effectively.

Dr. Graeme L. Conn's lab at Emory University focuses on understanding how bacterial enzymes modify ribosomal RNA to confer antibiotic resistance. By investigating the molecular details of these modifications, the lab aims to uncover new methods to combat bacterial infections and prolong the effectiveness of existing antibiotics.